Weisheng Liang

Title: Weisheng Liang: Innovator in Heparin Research

Introduction

Weisheng Liang is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical research, particularly in the area of heparin compositions and their therapeutic applications. With a total of 2 patents, Liang's work focuses on innovative methods for controlling the O-desulfation of heparin.

Latest Patents

Liang's latest patents include a method for controlling O-desulfation of heparin, which outlines techniques for making and using O-desulfated heparin compositions. These compositions are designed as prophylactics or therapeutics for preventing or treating diseases, including cancer. The methods allow for the regulation of the degree of 2-O and 3-O desulfation, producing compositions that can be variably desulfated up to about 99% and 75% at the respective positions.

Career Highlights

Weisheng Liang is currently associated with Glycomed, Inc., where he continues to advance his research in heparin applications. His work has the potential to impact the treatment of various diseases, showcasing his commitment to innovation in the biomedical field.

Collaborations

Liang has collaborated with notable colleagues, including Kevin R Holme and Patrick N Shaklee, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Weisheng Liang's contributions to heparin research exemplify the importance of innovation in medicine. His patents reflect a dedication to developing effective therapeutic solutions for critical health challenges.